MyFinsight
Home
About
Contact
aqst: the income statement
Download
Download image
Comprehensive loss
-$15,446K
(-34.21%↓ Y/Y)
Net loss
-$15,446K
(-34.21%↓ Y/Y)
Net loss before
income taxes
-$15,446K
(-34.21%↓ Y/Y)
Interest income and other
income, net
$306K
(-68.74%↓ Y/Y)
Co Development And
Research Fees
$302K
License And Royalty
Revenue
$1,038K
Manufacture And Supply
Revenue
$11,467K
Interest expense related
to the sale of...
$61K
(3.39%↑ Y/Y)
Interest expense related
to royalty...
$1,433K
(5.45%↑ Y/Y)
Interest expense
$2,779K
(-0.04%↓ Y/Y)
Loss from operations
-$11,479K
(-38.47%↓ Y/Y)
Revenues
$12,807K
(-5.43%↓ Y/Y)
Total costs and
expenses
$24,286K
(11.24%↑ Y/Y)
Selling, general and
administrative
$15,250K
(25.76%↑ Y/Y)
Research and development
$4,530K
(-14.03%↓ Y/Y)
Manufacture and supply
$4,506K
(1.56%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)